Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
           1.2.2  MARKETS COVERED 
           1.2.3  YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY 
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
                    2.1.1.1 KEY DATA FROM SECONDARY SOURCES
           2.1.2 PRIMARY DATA
                    2.1.2.1 KEY DATA FROM PRIMARY SOURCES
                    2.1.2.2 BREAKDOWN OF PRIMARIES
                    2.1.2.3 KEY INDUSTRY INSIGHTS
    2.2 MARKET SIZE ESTIMATION 
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.4 MARKET SHARE ESTIMATION 
    2.5 ASSUMPTIONS FOR THE STUDY 
    2.6 RISK ASSESSMENT 
    2.7 LIMITATIONS 
           2.7.1 SCOPE-RELATED LIMITATIONS
           2.7.2 METHODOLOGY-RELATED LIMITATIONS
    2.8 RECESSION IMPACT ANALYSIS 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
    4.1 MICROFLUIDICS: MARKET OVERVIEW 
    4.2 APAC: MICROFLUIDICS MARKET, BY TYPE 
    4.3 MICROFLUIDICS MARKET: GEOGRAPHIC MIX 
    4.4 MICROFLUIDICS BARRIER MARKET, BY REGION (2023-2028) 
    4.5 MICROFLUIDICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 INDUSTRY TRENDS 
    5.4 REGULATORY LANDSCAPE 
           5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.4.2 REGULATORY ANALYSIS
    5.5 KEY CONFERENCES & EVENTS IN 2023-2024 
    5.6 SUPPLY CHAIN ANALYSIS 
    5.7 VALUE CHAIN ANALYSIS 
    5.8 ECOSYSTEM MARKET MAP 
    5.9 PORTER'S FIVE FORCES ANALYSIS  
    5.10 PATENT ANALYSIS  
    5.11 TECHNOLOGY ANALYSIS 
    5.12 PRICING ANALYSIS 
           5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.12.2 AVERAGE SELLING PRICE TREND, BY COMPONENT
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 
           5.13.2 BUYING CRITERIA
    5.14 TRADE ANALYSIS  
    5.15 CASE STUDY ANALYSIS 
    5.16 END USER PERSPECTIVE AND UNMET NEEDS  
    5.17 AI INTEGRATION IN MICROFLUIDICS MARKET 
6 MICROFLUIDICS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) 
    6.1 INTRODUCTION 
    6.2 MICROFLUIDICS-BASED DEVICE 
    6.3 MICROFLUIDIC COMPONENTS 
           6.3.1 MICROFLUIDIC CHIP
           6.3.2 FLOW AND PRESSURE SENSORS
           6.3.3 FLOW AND PRESSURE CONTROLLERS
           6.3.4 MICROPUMPS
           6.3.5 MICROFLUIDIC VALVES
           6.3.6 MICRONEEDLES
           6.3.7 OTHER COMPONENTS
7 MICROFLUIDICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 
    7.1 INTRODUCTION 
    7.2 IN VITRO DIAGNOSTICS 
           7.2.1 CLINICAL DIAGNOSTICS
           7.2.2 POINT OF CARE TESTING
           7.2.3 VETERINARY DIAGNOSTICS
    7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING 
           7.3.1 LAB ANALYTICS
                    7.3.1.1 Proteomic analysis
                    7.3.1.2 Genomic analysis
                    7.3.1.3 Cell-based assays
                    7.3.1.4 Capillary electrophoresis
           7.3.2 MICRODISPENSING
           7.3.3 MICROREACTION
    7.4 THERAPEUTICS 
           7.4.1 DRUG DELIVERY
           7.4.2 WEARABLE DEVICES
8 MICROFLUIDICS MARKET, BY END-USER, 2021-2028 (USD MILLION) 
    8.1 INTRODUCTION 
    8.2 HOSPITAL AND DIAGNOSTIC CENTERS 
    8.3 ACADEMIC AND RESEARCH INSTITUTE 
    8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES  
9 MICROFLUIDICS MARKET, BY MATERIAL, 2021-2028 (USD MILLION) 
    9.1 GLASS 
    9.2 SILICON 
    9.3 POLYMER 
    9.4 OTHERS  
10 MICROFLUIDICS MARKET, BY REGION, 2021-2028 (USD MILLION) 
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 RECESSION IMPACT
             10.2.2 US
             10.2.3 CANADA
     10.3 EUROPE 
             10.3.1 RECESSION IMPACT
             10.3.2 GERMANY
             10.3.3 FRANCE
             10.3.4 UK
             10.3.5 ITALY
             10.3.6 SPAIN
             10.3.7 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 RECESSION IMPACT
             10.4.2 JAPAN
             10.4.3 CHINA
             10.4.4 INDIA
             10.4.5 AUSTRALIA
             10.4.6 SOUTH KOREA
             10.4.7 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA 
             10.5.1 RECESSION IMPACT
             10.5.2 BRAZIL
             10.5.3 MEXICO
             10.5.4 REST OF LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE 
     11.1 OVERVIEW 
     11.2 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022) 
     11.3 COMPANY EVALUATION MATRIX 
             11.3.1 STARS
             11.3.2 EMERGING LEADERS
             11.3.3 PERVASIVE PLAYERS
             11.3.4 PARTICIPANTS
             11.3.5 COMPANY FOOTPRINT ANALYSIS 
     11.4 START-UP/ SME EVALUATION MATRIX  
             11.4.1 PROGRESSIVE COMPANIES
             11.4.2 RESPONSIVE COMPANIES
             11.4.3 DYNAMIC COMPANIES 
             11.4.4 STARTING BLOCKS 
             11.4.5 COMPETITIVE BENCHMARKING
     11.5 MARKET SHARE ANALYSIS, BY KEY PLAYERS (2022) 
     11.6 COMPETITIVE SITUATION & TRENDS  
             11.6.1 PRODUCT LAUNCHES & APPROVALS
             11.6.2 DEALS
     11.7 R&D EXPENDITURE 
12 COMPANY PROFILES 
(Business Overview, Financials, Recent Developments, MnM View)
     12.1 KEY PLAYERS 
             12.1.1. THERMOFISHER
             12.1.2 PERKINELMER
             12.1.3 BECTON, DICKINSON, AND COMPANY
             12.1.4 AGILENT
             12.1.5 BIO-RAD
             12.1.6 F. HOFFMANN LA-ROCHE
             12.1.7 DANAHER CORPORATION
             12.1.8 ILLUMINA INC
             12.1.9 FLUIDIGM CORPORATION
             12.1.10 ABBOTT LABORATORIES
             12.1.12 BIOMÉRIEUX
             12.1.12 HOLOGIC
             12.1.13 QUIDEL CORPORATION
             12.1.14 SMC CORPORATION
             12.1.15 PARKER-HANNIFIN CORPORATION
             12.1.16 IDEX CORPORATION
             12.1.17 FORTIVE CORPORATION
             12.1.18 AIGNEP S.P.A
             12.1.19 DOLOMITE MICROFLUIDICS
             12.1.20 ELVEFLOW
     12.2 OTHER PLAYERS 
             12.2.1 UFLUIDIX
             12.2.2 NANOSTRING
             12.2.3 NORTIS INC. 
             12.2.4 INNOVATIVE BIOCHIPS, LLC
             12.2.5 FLUIDIC ANALYTICS
13 APPENDIX 
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 
     13.3 AVAILABLE CUSTOMIZATIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS